{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T22:27:06Z","timestamp":1795213626769,"version":"4.10.3"},"reference-count":129,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.autrev.2022.103212","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T14:20:35Z","timestamp":1665757235000},"page":"103212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Anti-glomerular basement membrane vasculitis"],"prefix":"10.1016","volume":"22","author":[{"given":"Claudio","family":"Ponticelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Calatroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103212_bb0005","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.01380217","article-title":"Anti-glomerular basement membrane disease","volume":"12","author":"McAdoo","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MAJ.0b013e31818fff94","article-title":"Landmark publication from the American journal of the medical sciences: the significance of certain pulmonary lesions in relation to the etiology of influenza","volume":"338","author":"Goodpasture","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.autrev.2022.103212_bb0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1445-5994.2011.02621.x","article-title":"Anti-glomerular basement membrane disease in Auckland","volume":"42","author":"Taylor","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2022.103212_bb0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","article-title":"Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study","volume":"90","author":"Cui","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2022.103212_bb0025","first-page":"108","article-title":"Diagnosis and classification of Goodpasture\u2019s disease (anti-GBM)","volume":"48\u201349","author":"Hellmark","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103212_bb0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/ckj\/sfw068","article-title":"Atypical anti-glomerular basement membrane disease: lessons learned","volume":"9","author":"Glassock","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2022.103212_bb0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0038-1669413","article-title":"Antiglomerular Basement Membrane Disease","volume":"39","author":"McAdoo","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0040","first-page":"9","article-title":"Inpatient burden and mortality of Goodpasture\u2019s syndrome in the United States: Nationwide inpatient sample 2003-2014","author":"Kaewput","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0045","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/ki.1996.495","article-title":"Goodpasture\u2019s syndrome","volume":"50","author":"Bolton","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0050","first-page":"14","article-title":"Seronegative Goodpasture\u2019s syndrome associated with organising pneumonia","author":"Bae","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2022.103212_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14740\/jocmr2379w","article-title":"Goodpasture\u2019s disease: an uncommon disease with an atypical clinical course","volume":"8","author":"Shiferaw","year":"2016","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.autrev.2022.103212_bb0060","first-page":"130","article-title":"Atypical Goodpasture\u2019s disease: a clinical case report and literature review","volume":"90","author":"Bulanova","year":"2018","journal-title":"Ter Arkh"},{"key":"10.1016\/j.autrev.2022.103212_bb0065","doi-asserted-by":"crossref","first-page":"2975131","DOI":"10.1155\/2019\/2975131","article-title":"Antibody-negative relapse of Goodpasture syndrome with pulmonary hemorrhage","volume":"2019","author":"Rohm","year":"2019","journal-title":"Case Rep Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1440-1797.2011.01511.x","article-title":"Circulating anti-glomerular basement membrane autoantibodies against \u03b13(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays","volume":"17","author":"Jia","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.autrev.2022.103212_bb0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.21037\/atm.2019.04.60","article-title":"Seronegative atypical anti-glomerular basement membrane crescentic glomerulonephritis","volume":"7","author":"Adapa","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0080","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/ndt\/11.11.2302","article-title":"Goodpasture\u2019s syndrome with normal renal function","volume":"11","author":"Min","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0085","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.kint.2016.02.001","article-title":"The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis","volume":"89","author":"Nasr","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0090","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3389\/fimmu.2019.01665","article-title":"Prognostic factors in anti-glomerular basement membrane disease: A multicenter study of 119 patients","volume":"10","author":"Marques","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103212_bb0095","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/ndt\/gfn761","article-title":"Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease","volume":"24","author":"Yang","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrneph.2013.118","article-title":"Vasculitis: validating the new classification system for ANCA-associated GN","volume":"9","author":"Kelsey","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0105","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.04290417","article-title":"Predicting outcome in patients with anti-GBM glomerulonephritis","volume":"13","author":"van Daalen","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0115","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/ndt\/gfg231","article-title":"Glomerular epithelial-mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis","volume":"18","author":"Bariety","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MNH.0000000000000596","article-title":"The glomerular crescent: triggers, evolution, resolution, and implications for therapy","volume":"29","author":"Anguiano","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.autrev.2022.103212_bb0125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ndt\/gfu399","article-title":"Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-Centre cohort","volume":"30","author":"Alchi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/0886022X.2020.1854301","article-title":"Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience","volume":"43","author":"Zahir","year":"2021","journal-title":"Ren Fail"},{"key":"10.1016\/j.autrev.2022.103212_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/ijn.IJN_414_19","article-title":"Recurrent, atypical anti-glomerular basement membrane disease","volume":"31","author":"Jamboti","year":"2022","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0140","first-page":"14","article-title":"Antiglomerular basement membrane (anti-GBM) disease with clinical and histological features that bridge the typical to atypical spectrum","author":"Fouhy","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2022.103212_bb0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ckj\/sfv140","article-title":"Atypical anti-glomerular basement membrane disease","volume":"9","author":"Troxell","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2022.103212_bb0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.humimm.2009.04.004","article-title":"The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity","volume":"70","author":"Zhao","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2022.103212_bb0155","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/S0270-9295(03)00131-1","article-title":"Pathogenesis of Goodpasture syndrome: a molecular perspective","volume":"23","author":"Borza","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0160","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/ndt\/gfy327","article-title":"Anti-glomerular basement membrane disease: an update on subgroups, pathogenesis and therapies","volume":"34","author":"Segelmark","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0165","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41581-020-0311-8","article-title":"Role of infection and molecular mimicry in the pathogenesis of anti-GBM disease","volume":"16","author":"Carney","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1081\/JDI-120013957","article-title":"Outcomes in patients with Goodpasture\u2019s syndrome and hydrocarbon exposure","volume":"24","author":"Shah","year":"2002","journal-title":"Ren Fail"},{"key":"10.1016\/j.autrev.2022.103212_bb0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa0910500","article-title":"Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis","volume":"363","author":"Pedchenko","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0180","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2215\/CJN.09930911","article-title":"Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury","volume":"7","author":"Jia","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0185","article-title":"Identification of critical residues of linear B cell epitope on Goodpasture autoantigen","volume":"10","author":"Jia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2022.103212_bb0190","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1172\/JCI119764","article-title":"Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice","volume":"100","author":"Kalluri","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103212_bb0195","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1046\/j.1523-1755.2003.00259.x","article-title":"Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture\u2019s (anti-GBM) disease","volume":"64","author":"Salama","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/BOR.0b013e328341009f","article-title":"Update on antiglomerular basement membrane disease","volume":"23","author":"Peto","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103212_bb0205","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1096\/fj.02-0746com","article-title":"The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice","volume":"17","author":"Hopfer","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2022.103212_bb0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-immunol-082119-124838","article-title":"T cell epitope predictions","volume":"38","author":"Peters","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2022.103212_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2017.05.011","article-title":"The critical amino acids of a nephritogenic epitope on human Goodpasture autoantigen for binding to HLA-DRB1*1501","volume":"88","author":"Gu","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2022.103212_bb0220","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/imm.12736","article-title":"The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture\u2019s disease","volume":"151","author":"Xie","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2022.103212_bb0225","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.4049\/jimmunol.172.7.4567","article-title":"A self T cell epitope induces autoantibody response: mechanism for production of antibodies to diverse glomerular basement membrane antigens","volume":"172","author":"Wu","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103212_bb0230","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2249.2008.03833.x","article-title":"Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis","volume":"155","author":"Reynolds","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2022.103212_bb0235","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/path.4046","article-title":"Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury","volume":"228","author":"Ryu","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2022.103212_bb0240","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","article-title":"Small-vessel vasculitis","volume":"337","author":"Jennette","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0245","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2006.01.026","article-title":"Renal involvement in Churg-Strauss syndrome","volume":"47","author":"Sinico","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103212_bb0250","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","article-title":"Clinical features and outcome of patients with both ANCA and anti-GBM antibodies","volume":"66","author":"Levy","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ajkd.2005.05.003","article-title":"Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis","volume":"46","author":"Rutgers","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103212_bb0260","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40620-017-0394-x","article-title":"Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis","volume":"30","author":"L\u2019Imperio","year":"2017","journal-title":"J Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0265","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/1319-2442.318529","article-title":"Anti-glomerular basement membrane disease with atypical associations","volume":"32","author":"Malviya","year":"2022","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.autrev.2022.103212_bb0270","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3389\/fimmu.2020.02035","article-title":"Clinical-pathological features and outcome of atypical anti-glomerular basement membrane disease in a large single cohort","volume":"11","author":"Shen","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103212_bb0275","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.autrev.2014.02.007","article-title":"Rapidly progressive crescentic glomerulonephritis: early treatment is a must","volume":"13","author":"Moroni","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103212_bb0280","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/1744-9987.13718","article-title":"Anti-glomerular basement membrane disease (Goodpasture disease): from pathogenesis to plasma exchange to IdeS","volume":"26","author":"Shin","year":"2022","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.autrev.2022.103212_bb0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12882-018-1038-7","article-title":"Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease","volume":"19","author":"Heitz","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0290","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2015.04.003","article-title":"Rituximab in anti-GBM disease: A retrospective study of 8 patients","volume":"60","author":"Touzot","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103212_bb0295","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/jama.1974.03230420056029","article-title":"Goodpasture syndrome with recovery after renal failure","volume":"229","author":"Strauch","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2022.103212_bb0300","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/oxfordjournals.ndt.a027848","article-title":"Complete recovery of renal function in a dialysis-dependent patient with Goodpasture syndrome","volume":"13","author":"Schindler","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0305","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/ajkd.2000.8993","article-title":"Immunoadsorption in Goodpasture\u2019s syndrome","volume":"36","author":"Laczika","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103212_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP59001","article-title":"Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease","volume":"59","author":"Deegens","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0315","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/ajkd.1998.v32.pm9708621","article-title":"Recurrent fulminant anti-glomerular basement membrane nephritis at a 7-year interval","volume":"32","author":"Fonck","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103212_bb0320","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ndt\/gfg393","article-title":"Recurrence of anti-GBM disease 8 years after renal transplantation","volume":"19","author":"Khandelwal","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12882-018-1197-6","article-title":"Recurrence of Goodpasture syndrome without circulating anti-glomerular basement membrane antibodies after kidney transplant, a case report","volume":"20","author":"Thibaud","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0330","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ekir.2021.04.011","article-title":"Recurrence and outcome of anti-glomerular basement membrane glomerulonephritis after kidney transplantation","volume":"6","author":"Coche","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2022.103212_bb0335","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport syndrome classification working group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0340","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","article-title":"Alport syndrome: achieving early diagnosis and treatment","volume":"77","author":"Kashtan","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103212_bb0345","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.00580116","article-title":"Alport syndrome in women and girls","volume":"11","author":"Savige","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0350","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2019.12.015","article-title":"A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport\u2019s syndrome","volume":"97","author":"Gross","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0355","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2215\/CJN.02190312","article-title":"Outcomes of male patients with Alport syndrome undergoing renal replacement therapy","volume":"7","author":"Temme","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0360","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1159\/000101791","article-title":"Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis","volume":"106","author":"Borza","year":"2007","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0365","doi-asserted-by":"crossref","first-page":"10670","DOI":"10.1074\/jbc.M611892200","article-title":"The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain","volume":"282","author":"Kang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2022.103212_bb0370","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1681\/ASN.2005060670","article-title":"Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0375","first-page":"148","article-title":"De-novo anti-GBM-antibody-induced glomerulonephritis in a renal transplant","volume":"23","author":"Boyce","year":"1985","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000168058","article-title":"Recurrent allograft antiglomerular basement membrane glomerulonephritis in a patient with Alport\u2019s syndrome","volume":"10","author":"Rassoul","year":"1990","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0385","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF00336209","article-title":"Failure of two subsequent renal grafts by anti-GBM glomerulonephritis in Alport\u2019s syndrome: case report and review of the literature","volume":"3","author":"Goldman","year":"1990","journal-title":"Transpl Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0390","first-page":"431","article-title":"Allograft rejection and glomerular basement membrane antibodies in Alport\u2019s syndrome","volume":"17","author":"Charytan","year":"2022","journal-title":"J Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0395","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1523-1755.2004.00428.x","article-title":"Retransplantation in Alport post-transplant anti-GBM disease","volume":"65","author":"Browne","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0400","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ekir.2018.01.008","article-title":"Genotype and outcome after kidney transplantation in Alport syndrome","volume":"3","author":"Gillion","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2022.103212_bb0405","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1399-3046.2006.00528.x","article-title":"Renal transplantation in patients with Alport syndrome","volume":"10","author":"Kashtan","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103030","article-title":"Pathogenesis-based new perspectives of management of ANCA-associated vasculitis","volume":"21","author":"Sciascia","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103212_bb0415","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0420","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ajkd.2005.05.003","article-title":"Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis","volume":"46","author":"Rutgers","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103212_bb0425","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10067-019-04854-1","article-title":"Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study","volume":"39","author":"Yoo","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103212_bb0430","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2016-209925","article-title":"Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis","volume":"76","author":"van Daalen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103212_bb0435","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1681\/ASN.2010090928","article-title":"Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease","volume":"22","author":"Olson","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0440","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.2169\/internalmedicine.8757-16","article-title":"The sequential development of Antiglomerular basement membrane nephritis and myeloperoxidase-antineutrophil cytoplasmic antibody-associated Vasculitis","volume":"56","author":"Ohashi","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0445","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2215\/CJN.04160413","article-title":"Glomerular diseases: membranous nephropathy--a modern view","volume":"9","author":"Ponticelli","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0450","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0455","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0460","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1681\/ASN.2020071082","article-title":"New antigens in membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0465","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2215\/CJN.00670112","article-title":"Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy","volume":"7","author":"van den Brand","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0470","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0475","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.ajkd.2020.11.023","article-title":"Concurrent anti-glomerular basement membrane antibody disease and membranous nephropathy: A case series","volume":"78","author":"Ahmad","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2022.103212_bb0480","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5414\/CNP66120","article-title":"Concurrent anti-glomerular basement membrane disease and membranous glomerulonephritis: a case report and literature review","volume":"66","author":"Troxell","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0485","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1681\/ASN.2010090923","article-title":"Membranous nephropathy with crescents","volume":"22","author":"Basford","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0490","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1681\/ASN.2006111210","article-title":"Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies","volume":"18","author":"Yang","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0495","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ki.2013.364","article-title":"The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy","volume":"85","author":"Jia","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2022.103212_bb0500","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10157-017-1465-y","article-title":"Clinicopathological and long-term prognostic features of membranous nephropathy with crescents: a Japanese single-center experience","volume":"22","author":"Saito","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0505","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ndt\/gfv384","article-title":"Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis","volume":"31","author":"Kanzaki","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0510","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13730-013-0071-4","article-title":"A case of anti-GBM glomerulonephritis superimposed on HBV-associated membranous nephropathy","volume":"2","author":"Yamamoto","year":"2013","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.autrev.2022.103212_bb0515","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/0971-4065.103924","article-title":"Transformation of membranous into anti-GBM nephritis","volume":"22","author":"Imtiaz","year":"2012","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0520","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000183294","article-title":"Transformation of membranous glomerulonephritis into crescentic glomerulonephritis with glomerular basement membrane antibodies. Serial determinations of anti-GBM before the transformation","volume":"38","author":"Kurki","year":"1984","journal-title":"Nephron"},{"key":"10.1016\/j.autrev.2022.103212_bb0525","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.semdp.2020.03.001","article-title":"IgA nephropathy: A brief review","volume":"37","author":"Hassler","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.autrev.2022.103212_bb0530","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","article-title":"Corticosteroids in IgA nephropathy: a randomised controlled trial","volume":"353","author":"Pozzi","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2022.103212_bb0535","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1681\/ASN.2014070697","article-title":"Corticosteroids in IgA nephropathy: A retrospective analysis from the VALIGA study","volume":"26","author":"Tesar","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0540","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00281-021-00888-3","article-title":"Current treatment of IgA nephropathy","volume":"43","author":"Floege","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2022.103212_bb0545","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/ckj\/sfs087","article-title":"IgA-mediated anti-glomerular basement membrane disease: an uncommon mechanism of Goodpasture\u2019s syndrome","volume":"5","author":"Moulis","year":"2012","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2022.103212_bb0550","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4132\/jptm.2019.08.05","article-title":"Concurrent anti-glomerular basement membrane nephritis and IgA nephropathy","volume":"53","author":"Suh","year":"2019","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0555","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pathol.2018.09.065","article-title":"Concurrent anti-GBM disease and IgA glomerulonephritis","volume":"51","author":"Longano","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.autrev.2022.103212_bb0560","first-page":"14","article-title":"Anti-glomerular basement membrane disease and IgA nephropathy in a patient with previous renal cell carcinoma","author":"Khor","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2022.103212_bb0565","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12882-019-1207-3","article-title":"Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report","volume":"20","author":"Kojima","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0570","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.4103\/1319-2442.220866","article-title":"Rapidly progressive glomerulonephritis due to anti-glomerular basement membrane disease accompanied by IgA nephropathy: an unusual association","volume":"28","author":"Annamalai","year":"2022","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.autrev.2022.103212_bb0575","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5414\/CN107213","article-title":"Rapidly progressive glomerulonephritis due to anti-glomerular basement membrane disease accompanied by IgA nephropathy: a case report","volume":"81","author":"Gao","year":"2014","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0580","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.autrev.2014.01.004","article-title":"Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification","volume":"13","author":"Shenkman","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103212_bb0585","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/17474086.2019.1611423","article-title":"An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura","volume":"12","author":"Joly","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.autrev.2022.103212_bb0590","first-page":"10","article-title":"Thrombotic thrombocytopenic Purpura: pathophysiology, diagnosis, and management","author":"Sukumar","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2022.103212_bb0595","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1093\/ndt\/gfq437","article-title":"Thrombotic thrombocytopenic purpura associated with anti-glomerular basement membrane disease","volume":"25","author":"Torok","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2022.103212_bb0600","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s10157-010-0312-1","article-title":"Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies","volume":"14","author":"Watanabe","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0605","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s11255-012-0279-9","article-title":"Goodpasture\u2019s syndrome associated with thrombotic thrombocytopenic purpura secondary to an ADAMTS-13 deficit","volume":"45","author":"Vega-Cabrera","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0610","first-page":"251","article-title":"A case of acute pulmonary hemorrhage and positive anti-glomerular basement membrane antibody in systemic lupus erythematosus","volume":"31","author":"Yamazaki","year":"1993","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"10.1016\/j.autrev.2022.103212_bb0615","first-page":"349","article-title":"An unusual association of anti-GBM diseases and lupus nephritis presenting as pulmonary renal syndrome","volume":"22","author":"Yadla","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.autrev.2022.103212_bb0620","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1272\/jnms.2018_85-21","article-title":"A case of anti-glomerular basement membrane antibody-positive systemic lupus erythematosus with pulmonary hemorrhage successfully treated at an early stage of the disease","volume":"85","author":"Yamada","year":"2018","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.autrev.2022.103212_bb0625","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/03009740500303181","article-title":"Clinical significance of anti-glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis","volume":"35","author":"Li","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103212_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.597863","article-title":"Absence of anti-glomerular basement membrane antibodies in 200 patients with systemic lupus erythematosus with or without lupus nephritis: results of the GOODLUPUS study","volume":"11","author":"Bourse Chalvon","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103212_bb0635","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/096120339300200207","article-title":"Clinical profile of Chinese patients with systemic lupus erythematosus","volume":"2","author":"Lee","year":"1993","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2022.103212_bb0640","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1681\/ASN.2006090992","article-title":"Severe lupus nephritis: racial differences in presentation and outcome","volume":"18","author":"Korbet","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2022.103212_bb0645","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ndt\/gfi230","article-title":"Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays","volume":"21","author":"Sinico","year":"2006","journal-title":"Nephrol Dial Transplant"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:27:25Z","timestamp":1761600445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222001823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1568997222001823"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103212","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-glomerular basement membrane vasculitis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103212"}}